一块石头的两只鸟:药物制度同时准病毒病原体阶段和COVID-19 ARDS
Ghazaleh Ghavami1, Soroush Sardari1
1Drug Design and Bioinformatics Unit, Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Infectious disorders drug targets
|January 30, 2024
概括
这项研究确定了乙氨基,乌尔索和β-胡卜素的三种药物组合作为严重的COVID-19和ARDS的潜在治疗方法. 这些重新设计的药物显示出对抗病毒性肺炎的多重向治疗有前途.
科学领域:
- 药理学 药理学是指药理学的学科.
- 病毒学 病毒学
- 计算生物学 计算生物学
背景情况:
- 严重的COVID-19包括病毒性肺炎和急性呼吸困难综合征 (ARDS).
- 目前的治疗方法包括抗病毒药物和免疫抑制剂,正在研究药物重定位.
- 了解病毒性肺炎和ARDS的综合病理对于有效的治疗策略至关重要.
研究的目的:
- 用计算方法识别潜在的药物组合来治疗严重的COVID-19和ARDS.
- 探索针对SARS-CoV-2的多目标治疗方法的药物重定向策略.
- 研究现有药物的协同效应,用于新的治疗应用.
主要方法:
- 在化生物标记向方法中使用,包括虚拟选和对接技术.
- 采用药物重新定位策略与数据挖掘和元分析相结合.
- 应用高通量对接和药物重新定位,用于识别组合疗法.
主要成果:
- 确定了乙氨基,乌尔索和β-胡卜素作为三种药物联合治疗.
- 这种疗法显示出治疗病毒性肺炎诱导的ARDS的潜力.
- 该组合对SARS-CoV-2感染表现出直接的抗病毒作用.
结论:
- 药物重新定位和高通量对接有助于开发用于COVID-19和ARDS的组合药物方案.
- 使用多个分子的多目标治疗策略显示出治疗这些疾病的前景.
- 这种方法凸显了药物重用在打击COVID-19大流行中的巨大潜力.
相关概念视频
Acute Respiratory Failure-V
140
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
140
COPD: Management Using Bronchodilators and Corticosteroids
207
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
207
Retrovirus Life Cycles
46.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.0K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Drug Administration and Therapy Phases: Overview
468
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
468
Pneumonia IV: Management
329
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
329


